ArticleMolecular biotechnology2026
SpyTag-Embedded Protein Nanoparticles Enable pH-Dependent Protein Loading.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional protein particles are emerging as versatile biomaterials with applications spanning nano-designs, drug delivery and biocatalysis. Their inherent biocompatibility, structural stability, and genetic modularity, when combined with nanoscale engineering, allow for the design of customizable systems with diverse functionalities. However, the reliable assembly of such nanostructures remains challenging due to the complexity of intermolecular interactions and surface charge variability. In this study, we present a modular strategy to assemble bioactive protein nanoparticles (NPs) using spontaneously crystallizing scaffolds derived from Bacillus thuringiensis. We generated stable, bioactive protein particles by genetically fusing the Cry1Ac scaffold to either monomeric red fluorescent protein or SpyTag002. These NPs maintained their structural integrity and fluorescence over extended period, highlighting their potential for sustained release applications. Modular recruitment on the NPs was achieved via the SpyTag/SpyCatcher system, a highly specific and covalent protein conjugation strategy, enabling targeted loading of functional proteins to the particle surface. Interestingly, SpyTag-embedded NPs exhibited pH-dependent binding to SpyCatcher, confirming the platform's pH-responsive functionality. The pH sensitivity and stability of these NPs position them as promising candidates for therapeutic delivery in acidic microenvironments, such as tumor tissues.
Indexed as
Identifiers
42570065What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.